NEW YORK (GenomeWeb News) – Sequenom said today that it has agreed to pay $14 million to shareholders to settle their class action lawsuit against the company.

Sequenom said that the settlement will be funded by insurance proceeds. Additionally, the company has agreed to issue to the plaintiffs a number of shares of Sequenom common stock, to be determined after final approval of the settlement by the US District Court.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.